Skip to main content

Table 4 Comparison between the BD and Non-BD groups

From: Diagnosis of Behçet’s disease: clinical characteristics, diagnostic criteria, and differential diagnoses

Symptom/Sign/Lab test BD group, No. positive (percent) Non-BD group, No. positive (percent) P-value
Oral lesions 40 (100%) 83 (89.25%) 0.031
Genital lesions 26 (65%) 17 (18.28%) <  0.001
Ocular lesions 20 (50%) 13 (13.98%) <  0.001
Erythema Nodosum 11 (27.5%) 0 (0%) <  0.001
Articular involvement 10 (25%) 13 (14%) 0.123
Pseudofolliculitis 3 (7.5%) 0 (0%) 0.008
Gastrointestinal 3 (7.5%) 12 (12.9%) 0.18
Cardiovascular 2 (5%) 2 (2.1%) 0.51
Neurologic involvement 1 (2.5%) 2 (2.1%) 0.9
Positive Pathergy reaction 18 (45%) 0 <  0.001
Leukocyte antigens
 HLA-B5 26 (65%) 46 (49%) 0.09
HLA-B51 24 (60%) 36 (38%) 0.02
 HLA-B27 3 (7.5%) 9 (9.6%) 0.68
  1. History, physical examination, and laboratory tests compared between BD and Non-BD groups, sorted by decreasing frequency in the BD group. Significant comparisons are indicated in bold